Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03182959 · ClinicalTrials.gov registry record · Early Phase 1
Broccoli Sprout Extract in Preventing Recurrence in Patients With Tobacco-Related Head and Neck Squamous Cell Cancer
A Early Phase 1 study, sponsored by University of Arizona.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 6
- Enrollment target
NCT03182959 is a Early Phase 1 study that has completed, run by University of Arizona. The registered enrollment target is 6 participants.
The verdict
NCT03182959, a Early Phase 1 study, has completed, sponsored by University of Arizona.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 6 participants
- Enrollment target
Study Summary
This study is being done to see whether Avmacol®, a dietary supplement made from broccoli sprout and seed extract powder, induces changes in inner cheek cells that may be protective against environmental toxins such as tobacco. There are three main goals of the study: 1. To learn whether the dietary supplement, Avmacol®, can stimulate cheek cells to repair damage from environmental toxins; 2. to learn how the body metabolizes Avmacol®, by measuring its byproducts in the participant's urine and blood; 3. to learn whether the immune system can be stimulated by Avmacol®, by studying the natural killer cells and T cells in the participant's blood.
Interventions
- DRUG Avmacol®
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2017-04-24 |
| Est. Completion | 2021-01-19 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03182959
The ClinicalTrials.gov registry entry for NCT03182959 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Arizona, which has 349 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Avmacol® is the first listed.
NCT03182959 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03182959 about?
NCT03182959 is a clinical study titled "Broccoli Sprout Extract in Preventing Recurrence in Patients With Tobacco-Related Head and Neck Squamous Cell Cancer". This study is being done to see whether Avmacol®, a dietary supplement made from broccoli sprout and seed extract powder, induces changes in inner cheek cells that may be protective against environmental toxins such as tobacco. There are three main goals of the study: 1. To learn whether the dieta...
What is the current status of trial NCT03182959?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 6 participants. The study started on 2017-04-24. Estimated completion is 2021-01-19.
What interventions are being tested in trial NCT03182959?
The interventions under investigation include: Avmacol® (DRUG).
Who is sponsoring clinical trial NCT03182959?
This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.